Self-reported quality of life in patients with diabetes

A comparison of patients with and without charcot neuroarthropathy

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background: Previous reports using the Short Form-36 as a generic measure of quality of life have demonstrated reduced quality of life in patients with Charcot neuroarthropathy (CN). The aim of this study was to assess self-reported quality of life using the SF-36 and a region-specific assessment (the Foot and Ankle Ability Measure [FAAM]), hypothesizing that patients with diabetes and CN would have lower self-reported scores than patients with diabetes and no foot disease. Methods: Fifty patients with diabetes and CN were included in the study group. Fifty-six patients with diabetes and no pedal complaints comprised the control group. Quality of life was assessed with the SF-36 and the FAAM. Results: Patients with CN were more likely to have type 1 diabetes mellitus, were more likely to use insulin, had greater duration of diabetes, and were more likely to be neuropathic than patients in the control group. Patients with CN reported mean FAAM activities of daily living (ADL) scores that were 2 standard deviations below the control group and sports scores that were 1 standard deviation lower. There was no notable difference between the SF-36 mental component summary scores between the CN and control groups. SF-36 physical component summary scores in patients with CN were notably lower than scores in the control group. Conclusion: CN is associated with reduced quality of life as measured with the SF-36 and FAAM. To the best of our knowledge, this is the first study directly comparing self-reported outcome assessments in patients with both diabetes and CN and patients with diabetes without foot complaints. Level of Evidence: Level III, comparative series.

Original languageEnglish (US)
Pages (from-to)195-200
Number of pages6
JournalFoot and Ankle International
Volume35
Issue number3
DOIs
StatePublished - Mar 1 2014

Fingerprint

Quality of Life
Foot
Ankle
Control Groups
Patient Outcome Assessment
Foot Diseases
Activities of Daily Living
Type 1 Diabetes Mellitus
Sports
Insulin

Keywords

  • charcot neuroarthropathy
  • diabetes
  • FAAM
  • quality of life
  • SF-36

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

@article{a1e36232ca1a401cbe5a0cddd134eca2,
title = "Self-reported quality of life in patients with diabetes: A comparison of patients with and without charcot neuroarthropathy",
abstract = "Background: Previous reports using the Short Form-36 as a generic measure of quality of life have demonstrated reduced quality of life in patients with Charcot neuroarthropathy (CN). The aim of this study was to assess self-reported quality of life using the SF-36 and a region-specific assessment (the Foot and Ankle Ability Measure [FAAM]), hypothesizing that patients with diabetes and CN would have lower self-reported scores than patients with diabetes and no foot disease. Methods: Fifty patients with diabetes and CN were included in the study group. Fifty-six patients with diabetes and no pedal complaints comprised the control group. Quality of life was assessed with the SF-36 and the FAAM. Results: Patients with CN were more likely to have type 1 diabetes mellitus, were more likely to use insulin, had greater duration of diabetes, and were more likely to be neuropathic than patients in the control group. Patients with CN reported mean FAAM activities of daily living (ADL) scores that were 2 standard deviations below the control group and sports scores that were 1 standard deviation lower. There was no notable difference between the SF-36 mental component summary scores between the CN and control groups. SF-36 physical component summary scores in patients with CN were notably lower than scores in the control group. Conclusion: CN is associated with reduced quality of life as measured with the SF-36 and FAAM. To the best of our knowledge, this is the first study directly comparing self-reported outcome assessments in patients with both diabetes and CN and patients with diabetes without foot complaints. Level of Evidence: Level III, comparative series.",
keywords = "charcot neuroarthropathy, diabetes, FAAM, quality of life, SF-36",
author = "Raspovic, {Katherine M.} and Wukich, {Dane K.}",
year = "2014",
month = "3",
day = "1",
doi = "10.1177/1071100713517097",
language = "English (US)",
volume = "35",
pages = "195--200",
journal = "Foot and Ankle International",
issn = "1071-1007",
publisher = "AOFAS - American Orthopaedic Foot and Ankle Society",
number = "3",

}

TY - JOUR

T1 - Self-reported quality of life in patients with diabetes

T2 - A comparison of patients with and without charcot neuroarthropathy

AU - Raspovic, Katherine M.

AU - Wukich, Dane K.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Background: Previous reports using the Short Form-36 as a generic measure of quality of life have demonstrated reduced quality of life in patients with Charcot neuroarthropathy (CN). The aim of this study was to assess self-reported quality of life using the SF-36 and a region-specific assessment (the Foot and Ankle Ability Measure [FAAM]), hypothesizing that patients with diabetes and CN would have lower self-reported scores than patients with diabetes and no foot disease. Methods: Fifty patients with diabetes and CN were included in the study group. Fifty-six patients with diabetes and no pedal complaints comprised the control group. Quality of life was assessed with the SF-36 and the FAAM. Results: Patients with CN were more likely to have type 1 diabetes mellitus, were more likely to use insulin, had greater duration of diabetes, and were more likely to be neuropathic than patients in the control group. Patients with CN reported mean FAAM activities of daily living (ADL) scores that were 2 standard deviations below the control group and sports scores that were 1 standard deviation lower. There was no notable difference between the SF-36 mental component summary scores between the CN and control groups. SF-36 physical component summary scores in patients with CN were notably lower than scores in the control group. Conclusion: CN is associated with reduced quality of life as measured with the SF-36 and FAAM. To the best of our knowledge, this is the first study directly comparing self-reported outcome assessments in patients with both diabetes and CN and patients with diabetes without foot complaints. Level of Evidence: Level III, comparative series.

AB - Background: Previous reports using the Short Form-36 as a generic measure of quality of life have demonstrated reduced quality of life in patients with Charcot neuroarthropathy (CN). The aim of this study was to assess self-reported quality of life using the SF-36 and a region-specific assessment (the Foot and Ankle Ability Measure [FAAM]), hypothesizing that patients with diabetes and CN would have lower self-reported scores than patients with diabetes and no foot disease. Methods: Fifty patients with diabetes and CN were included in the study group. Fifty-six patients with diabetes and no pedal complaints comprised the control group. Quality of life was assessed with the SF-36 and the FAAM. Results: Patients with CN were more likely to have type 1 diabetes mellitus, were more likely to use insulin, had greater duration of diabetes, and were more likely to be neuropathic than patients in the control group. Patients with CN reported mean FAAM activities of daily living (ADL) scores that were 2 standard deviations below the control group and sports scores that were 1 standard deviation lower. There was no notable difference between the SF-36 mental component summary scores between the CN and control groups. SF-36 physical component summary scores in patients with CN were notably lower than scores in the control group. Conclusion: CN is associated with reduced quality of life as measured with the SF-36 and FAAM. To the best of our knowledge, this is the first study directly comparing self-reported outcome assessments in patients with both diabetes and CN and patients with diabetes without foot complaints. Level of Evidence: Level III, comparative series.

KW - charcot neuroarthropathy

KW - diabetes

KW - FAAM

KW - quality of life

KW - SF-36

UR - http://www.scopus.com/inward/record.url?scp=84896782624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896782624&partnerID=8YFLogxK

U2 - 10.1177/1071100713517097

DO - 10.1177/1071100713517097

M3 - Article

VL - 35

SP - 195

EP - 200

JO - Foot and Ankle International

JF - Foot and Ankle International

SN - 1071-1007

IS - 3

ER -